Skip to content
facebook
twitter
linkedin
THERADNET
International Network for Training and Innovation in Therapeutic Radiation
  • HOME
  • Network
    • EARLY STAGE RESEARCHERS
    • PARTNERS
    • MANAGEMENT TEAM
    • ASSOCIATED PARTNERS
    • ADVISORY BOARD
    • BENEFICIARY SITES
  • Science
    • Research Projects
      • TUMOR SENSITIZATION
      • NORMAL TISSUE PROTECTION
      • ADAPTATION AND ESCAPE
    • PUBLICATIONS
  • TRAININGS
  • Contact
  • Meetings & Workshops
    • MEETINGS
    • WORKSHOPS
  • Intranet

Latest News
5th THERADNET Workshop and NVRB Symposium in Utrecht (8-11 November 2022)
Third THERADNET workshop and NVRB-symposium in Utrecht From 8th to 11th of November 2022, we met in Utrecht to enjoy...
Razan’s secondment in Dresden
Razan has enjoyed a wonderful time in Dresden, where she performed her first secondment at OncoRay. According to Razan, the...
Safa did her first secondment in the Sonveaux lab!
During the whole month of May, Safa had a great opportunity to perform my secondment in the beautiful city of...
4th THERADNET workshop (7-9 June 2022) : Second THERADNET on-site meeting in beautiful Piedmont
Second THERADNET on-site meeting in beautiful Piedmont! From 7th to 9th of June 2022, we enjoyed a highly productive and...
Transferable Course in Publication Ethics and Scientific Integrity… Read the summary of the recent THERADNET seminar with Prof. Roberto Andorno here
During the THERADNET meeting in Ca’ San Sebastiano, Italy, the ESRs attended a course on scientific ethics with Professor Roberto...
Article on THERADNET published in EACR magazine The Cancer Researcher
Check out what THERADNET is all about in this article recently published in collaboration with EACR, one of our non-academic...


The THERADNET project is an innovative training network with the goal to integrate novel-emerging tumor-biological concepts into current standard-of-care to improve the outcome of radiotherapy-treated cancer patients. Approximately 50% of all cancer patients in Europe have an indication for radiotherapy at least once during the course of their disease, with an absolute number of patients steadily increasing assuming overall cancer rates remain unchanged. Advances in the modern radiotherapy could greatly increase chances of surviving cancer and improve the quality of life of treated patients.

THERADNET improves collaborative scientific action for researchers interested in radiotherapy. THERADNET covers a research program across 21 academic and non-academic, industry partners and brings together a multidisciplinary faculty of scientists and research-oriented clinicians who are well qualified and experienced in supervision.

THERADNET will prepare a new generation of highly competent and translational research-oriented early-stage researchers to expedite discovery and clinical translation in radiation research and oncology.  With a view to finding novel strategies to cure cancer through radiotherapy, THERADNET will integrate novel radiobiological insights into clinical and technological approaches.

Funding

This project has received funding from the European Union’s Horizon 2020  research and innovation programme under the Marie Skłodowska-Curie grant agreement No 860245

Contact

THERADNET
Martin Pruschy
Laboratory for Applied Radiobiology
Dept. of Radiation Oncology
University Hospital Zurich
theradnet@physiol.uzh.ch

Follow our blog

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

© 2023 THERADNET